Self-constrained DNAzyme for aptamer-based and sensitive label-free fluorescent assay of sarafloxacin via signal amplification cascades
The Analyst · 2023
DOI: 10.1039/d3an00476g ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2023. Verfasst von Qianying Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Luminescent and Real-Time Analytical Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Southwest Univ…. Hauptthemen laut MEDLINE: DNA, Catalytic, Aptamers, Nucleotide, Biosensing Techniques, G-Quadruplexes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Target-induced activation of self-constrained DNAzyme leads to a dual signal amplification cascade for label-free and highly sensitive fluorescent sensing of sarafloxacin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Luminescent and Real-Time Analytical Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, PR China. yunatswu@swu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Zhang, J., Yuan, R., & Xiang, Y. (2023). Self-constrained DNAzyme for aptamer-based and sensitive label-free fluorescent assay of sarafloxacin via signal amplification cascades. The Analyst. https://doi.org/10.1039/d3an00476g
Vancouver
Wang Q, Zhang J, Yuan R, Xiang Y. Self-constrained DNAzyme for aptamer-based and sensitive label-free fluorescent assay of sarafloxacin via signal amplification cascades. The Analyst. 2023. doi:10.1039/d3an00476g
BibTeX
@article{Wang2023,
author = {Wang, Qianying and Zhang, Junyi and Yuan, Ruo and Xiang, Yun},
title = {Self-constrained DNAzyme for aptamer-based and sensitive label-free fluorescent assay of sarafloxacin via signal amplification cascades},
journal = {The Analyst},
year = {2023},
doi = {10.1039/d3an00476g}
}
EUVIMED